Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

The Ki-67 antigen is used to evaluate the proliferative activity of breast cancer (BC); however, Ki-67's role as a prognostic marker in BC is still undefined. In order to better define the prognostic value of Ki-67/MIB-1, we performed a meta-analysis of studies that evaluated the impact of Ki-6...

Descripción completa

Detalles Bibliográficos
Autores principales: de Azambuja, E, Cardoso, F, de Castro, G, Colozza, M, Mano, M S, Durbecq, V, Sotiriou, C, Larsimont, D, Piccart-Gebhart, M J, Paesmans, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359936/
https://www.ncbi.nlm.nih.gov/pubmed/17453008
http://dx.doi.org/10.1038/sj.bjc.6603756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359936/
https://www.ncbi.nlm.nih.gov/pubmed/17453008
http://dx.doi.org/10.1038/sj.bjc.6603756

Ejemplares similares